e9 Breakdance Boilerplate Logo
Enrollment Engine: Patient identification

Precise identification: matching patients to protocols

Every study is unique so enrollment strategies are customized based on protocol eligibility and requirements. 

CTM brings a curated mix of direct-to-patient outreach solutions, partners, and channels together to hit enrollment goals with precision and efficiency.

Patient Community

Explore Clinical Research™ (ECR): a community ready for recruitment

CTM's proprietary community of 3M+ individuals have opted in to match with clinical trials in an extensive range of therapeutic areas. CTM communication helps community members better understand clinical research and builds increased confidence in participation before the right study opportunity arises. Ongoing engagement keeps members ready and responsive between studies, improving follow-through when they are matched with a trial.
3M+
individuals opted in to match with clinical trials
SEGMENTABLE DOWN TO THE PROTOCOL

Diagnosis, treatment history, symptoms, demographics, and geography enable protocol-level matching

Protocol level match
DAY ONE PATIENT MATCHING

Patients can be screened and delivered immediately upon site activation.

OMNICHANNEL ENGAGEMENT

Direct to patient outreach: finding patients where they are

Direct to patient outreach is at the core of CTM’s expertise. For more than 30 years, we’ve adapted alongside changing patient behavior, media channels, and increasingly complex clinical trial protocols — continually evolving how we find and engage the patients most likely to qualify.

Decades of enrollment intelligence inform where we start; real-time performance tells us where to go next. CTM builds each outreach strategy around the protocol and patient population, using data to determine the channels most likely to reach and convert qualified patients.

CTM selects channels based on where the right patient population can most effectively be reached, including:

  • Digital media, streaming and connected TV, traditional media
  • Awareness and education through HCP campaigns, local community activation, and advocacy engagement
  • Partner networks including: labs, pharmacies, healthcare & niche patient communities

Our approach ensures that sponsors can work with multiple partners within one global enrollment engine, ensuring strategic implementation across one workstream.

Activating all of the channels, as appropriate for the study, enables us to complete enrollment faster

months saved

on enrollment timeline

Immunology study
MAXIMIZING MEDIA SPEND

StudyMax Media™: precision media for smarter recruitment

Anyone can place advertising but only CTM can deliver qualified patients for randomization with scale, speed, and efficiency, maximizing ROI right from the start

StudyMax Media is CTM’s proprietary AI-enabled software, built on 30 years of clinical trial enrollment data and hundreds of millions of data points, to make every digital advertising decision smarter. StudyMax™ Media powers industry-leading results for qualified patient access and identification. 

Our integrated media platform leverages real-time signals from campaign performance and screening data to drive algorithms to best match audiences with trial protocols.

Coupled with RandIQ™, our predictive enrollment solution, CTM can precisely identify patients across populations, demographics, geographies, and complex cohort stratifications.

randomizations delivered

Alzheimer’s study
DRIVING INCLUSIVITY

DiversityMax™: enrolling underrepresented populations

This one-of-a-kind product harnesses our precise targeting capabilities to specifically index on underrepresented patient populations at speed and scale, especially for indications that disproportionately affect those populations.
Share of CTM randomizations from diverse populations on recent studies
HEADQUARTERS
100 Motor Parkway, Suite 528
Hauppauge, NY 11788